Real-time enrollment status for this symptomatic genetic dilated cardiomyopathy (dcm) clinical trial
Current Status
Recruiting
Checked: September 2, 2026 at 8:17 PM UTC
| NCT Number | NCT07771465 |
| Recruiting Status | Recruiting |
| Condition | Symptomatic Genetic Dilated Cardiomyopathy (DCM) |
| Phase | PHASE3 |
| Target Enrollment | 332 participants |
| Active Locations | 28 sites in the US |
| Sponsor | Kardigan, Inc. |
| Last Updated on CT.gov | September 2, 2026 (20 hours ago) |
As of September 2, 2026: Clinical trial NCT07771465 is currently recruiting participants. This phase3 study for symptomatic genetic dilated cardiomyopathy (dcm) is actively seeking new participants at 28 locations across the United States. The study is sponsored by Kardigan, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07771465 is actively recruiting participants as of September 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 28 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07771465 was last updated 20 hours ago (September 2, 2026). HelloStudys verifies this status automatically.